Amarantus BioSciences Announces the Release of Research Report by TomorrowsBlueChips.com SUNNYVALE, Calif., July 11, 2012 (GLOBE NEWSWIRE) -- Amarantus BioSciences Inc. (OTCBB:AMBS), a California-based biotechnology company focused on the development of a therapeutic protein known as...

Amarantus BioSciences' CEO Gerald Commissiong to Appear on the Big Biz Radio Show SUNNYVALE, Calif., March 16, 2012 (GLOBE NEWSWIRE) -- Amarantus BioSciences, Inc. (OTCBB:AMBS), a biotechnology company developing MANF, a first-in-class disease-modifying therapeutic protein, today...

Amarantus Biosciences Releases New Video Interview With President and CEO Gerald Commissiong SUNNYVALE, Calif., Jan. 6, 2012 (GLOBE NEWSWIRE) -- Amarantus BioSciences Inc. (OTCBB:AMBS) is a biopharmaceutical company that has discovered a revolutionary therapeutic protein that could change the...

New Webcast Interview With President and CEO Gerald Commissiong Now Available at TheGreenBaron.com SUNNYVALE, Calif., Nov. 29, 2011 (GLOBE NEWSWIRE) -- Amarantus BioSciences, Inc. (OTCBB:AMBS), a biotechnology company developing MANF, a first-in-class disease–modifying therapeutic protein,...

Amarantus Biosciences, a Promising Biotech Company in Development MIAMI, Nov. 14, 2011 (GLOBE NEWSWIRE) -- Founded in California in 2008, Amarantus Biosciences, Inc. (OTCBB:AMBS) is now poised to take the biotech world by storm with their proprietary new technology....